Where innovation moves us

Stay updated with our latest news and see how we’re making a difference.

All - Spineart - post
Date - Category Illustration Title Excerpt
  • Product
Spineart is pleased to announce the first implantation of the Lateral Ti-LIFE cage JULIET®Ti LL in Australia. Dr Ivan Bhaskar, neurosurgeon, successfully performed the procedure in St Vincent Hospital in...
  • Clinical
​Spineart is proud to announce the “Best in class” award given to Dr. Jesús PINO for his presentation of the experimental work with Ti-LIFE Technology cages in an in vivo...
  • Corporate
​Spineart is happy to be joining with Hotel Management International (HMI) in supporting the Geneva Red Cross this holiday season. In this particularly challenging year the Geneva Red Cross has needed donations more than...
  • Product
Following its success in the US and Europe, Spineart is proud to announce the first Australian surgical case using PERLA® TL, the new Posterior Thoracolumbar Fixation System. On November 18th 2020, Dr. Neil COCHRANE from Sunnybank, QLD...
  • Product
Spineart is proud to announce the first worldwide surgery using SCARLET® AL-T HL, the new Hyperlordotic Secured Lumbar Anterior Cage. On November 10th 2020, surgery with the new SCARLET® AL-T HL Hyperlordotic...
  • BAGUERA® C
Following the recent FDA approval to initiate a pivotal IDE clinical study for the BAGUERA® C artificial cervical disc at 1-level, Spineart is proud to announce that it has received approval...
  • Product
Spineart is proud to announce the first surgeries of PERLA® TL, the new Posterior Thoracolumbar Fixation System. On August 17th 2020, the first world-wide surgery with the new PERLA® TL Posterior Thoracolumbar Fixation System was...
  • Product
Spineart is proud to announce the first surgeries of TRYPTIK®Ti, the new Cervical Cage System. On August 24th 2020, the first world-wide surgery with the new TRYPTIK®Ti Cervical Cages was successfully...
  • Product
Spineart is proud to announce the first SCARLET® AL-T ALIF surgeries have been carried out in the UK. The surgeries were successfully completed using our Ti-LIFE Technology cage in the...
  • BAGUERA® C
Spineart is pleased to announce that it has received Investigational Device Exemption (IDE) approval from the FDA to initiate a clinical trial to determine the safety and effectiveness of the BAGUERA® C Cervical...
  • Product
Spineart USA announces over 1,000 patients treated with SCARLET® AL-T, its ALIF system launched in 2019. The implant was developed using the company’s flagship Ti-LIFE Technology, a titanium bone-like structure...
  • Product
Spineart is proud to announce the first TEKTONA® Vertebral Fragment Reduction surgery in Colombia. The surgery has been successfully performed by Dr Cesar DIAZ, Neurosurgeon in Hospital San Rafael de...